business
AU & NZ ENTERPRISE PROFILES

Neuren Pharmaceuticals Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: NEU

What does Neuren Pharmaceuticals Limited do?

Neuren Pharmaceuticals Limited is a foreign owned publicly listed company that derives its revenue from the development of drugs for neurological orders. The company employs approximately 7 employees, operates in Australia, New Zealand and the United States, and is administered by its head office in Auckland, New Zealand.

Neuren Pharmaceuticals Limited is listed on the Australian Securities Exchange under the code NEU.

Neuren Pharmaceuticals Limited - Products & Brands

Neuren Pharmaceuticals Limited is a biopharmaceutical company that develops drugs for neurological disorders such as Trofinetide (NNZ-2566) for Rett syndrome and Fragile X syndrome, and NNZ-2591 for Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome.

IBISWorld provides enterprise profiles on thousands of leading organizations across Australia and New Zealand.

LEARN MORE

Neuren Pharmaceuticals Limited - Financial Statements

pie_chart Neuren Pharmaceuticals Limited Financial Profit & Loss Account

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/2017
Sales RevenueN/A0000
Other Revenue0000000000000000000000000
Total Revenue0000000000000000000000000
Cost of Goods Sold0000000000000000000000000
Depreciation0000000000000000000000000
R & D Expenditure0000000000000000000000000
lock To view Neuren Pharmaceuticals Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Neuren Pharmaceuticals Limited - Financial Ratios

pie_chart Neuren Pharmaceuticals Limited Financial Growth

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/2017
Total Revenue Growth277.17-5.11-93.3049.30204.37
Sales Revenue Growth0000000000000000000000000
EBITDA0000000000000000000000000
NPAT0000000000000000000000000
Shareholder's Funds0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000

pie_chart Neuren Pharmaceuticals Limited Financial Ratios

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/2017
Return on Revenue (ROR) (%)-214.4-953.6-1064.620.332.4
Return on Shareholders’ Funds (ROSF) (%)0000000000000000000000000
Return on Assets (ROA) (%)0000000000000000000000000
Profit Margin (%)0000000000000000000000000
Revenue per Employee ($’000 per person)0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000
lock To view Neuren Pharmaceuticals Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Neuren Pharmaceuticals Limited's Competitive Environment

Neuren Pharmaceuticals Limited operates in the following industries:

Neuren Pharmaceuticals Limited's main competitors:

  • CSL Limited
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
lock To view Neuren Pharmaceuticals Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Company Profiles - table of contents

A high-level overview of Neuren Pharmaceuticals Limited’s registered business details, a company synopsis, history and background, as well as Neuren Pharmaceuticals Limited’s main brands and products.

We outline the Neuren Pharmaceuticals Limited’s key personnel by position type and title.

Get a full view of Neuren Pharmaceuticals Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Understand the main operating divisions of Neuren Pharmaceuticals Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Neuren Pharmaceuticals Limited operates in.

Understand the competitive threats and opportunities within the industries Neuren Pharmaceuticals Limited operates in. Gain insight into the industry trends and competitive forces that Neuren Pharmaceuticals Limited is exposed to.

We outline Neuren Pharmaceuticals Limited’s ultimate parent and largest shareholders.

A list of Neuren Pharmaceuticals Limited’s associated companies, holding company and trusts.

Where available, we provide details of Neuren Pharmaceuticals Limited’s banker, external auditor, insurance broker, internal auditor, solicitor and telecommunication provider.

Purchase to Read Full Report

100% Money Back Guarantee Digicert Trusted

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Enterprise Financial Statements
  • Financial Ratios
    Financial Ratios
  • Industry Averages
    Industry Averages
  • Competitive Landscape
    Competitive Landscape
  • Key Enterprise Personnel
    Key Enterprise Personnel
  • Subsidiaries & Ownership Structure
    Subsidiaries & Ownership Structure

Why buy this enterprise profile on Neuren Pharmaceuticals Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on Neuren Pharmaceuticals Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal